股票代码：000538 股票简称：云南白药 公告编号：2026-07 云南白药集团股份有限公司 关于股东部分股份质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 云南白药集团股份有限公司（以下简称"公司"或"云南白药"）于近 日接到公司股东新华都实业集团股份有限公司（以下简称"新华都"）的通 知，获悉新华都将其持有的公司部分股份办理了质押。具体情况如下： 质押股份是否负担重大资产重组等业绩补偿义务：否。 二、股东股份累计质押情况 截至本公告披露日，新华都及其一致行动人所持质押股份情况如下： | | | | | | | | 已质押股份情况 | | 未质押股份 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 本次质押前 | 本次质押后 | | 占公司 | | | 情况 | | | 股东名 | 持股数量 | 持股比 | 质押股份数 | 质押股份数 | 占其所持 | 总股本 | 已质押股 | 占已质 | 未质押股份 | 占未 | | 称 | （股） ...

[Table_Report] 相关报告 高频选股因子周报（20260316-20260320） 2026.03.22 低频选股因子周报（2026.03.13-2026.03.20） 2026.03.21 量化择时和拥挤度预警周报（20260320） 2026.03.21 红利风格择时周报（0316-0320） 2026.03.21 绝对收益产品及策略周报（260309-260313） 2026.03.18 大额买入与资金流向跟踪（20260316-20260320） [Table_Authors] 郑雅斌(分析师) 本报告导读： 参考团队前期发布的专题报告选股因子系列研究（五十六、五十七），本报告旨在通 过交易明细数据构建相关指标，跟踪大额买入和净主动买入。 投资要点： | | 021-23219395 | | --- | --- | | | zhengyabin@gtht.com | | 登记编号 | S0880525040105 | | | 张耿宇(分析师) | | | 021-23183109 | | | zhanggengyu@gtht.com | | 登记编号 | S0880525040078 | ...

Core Viewpoint - Yunnan Baiyao Group Co., Ltd. has approved the conversion of HKD 500 million convertible bonds into shares of Yunbai International Limited, ensuring compliance with public shareholding requirements [2][3]. Group 1 - The company held a board meeting on October 29, 2024, where it approved the handling of the convertible bonds issued by Yunbai International [2]. - The company will exercise its right to convert the HKD 500 million convertible bonds into shares once the public shareholding requirements are met [2][3]. - The conversion will result in the issuance of 1,937,984,496 shares at a conversion price of HKD 0.258 per share, representing approximately 25.50% of Yunbai International's total shares before conversion and about 20.32% after conversion [3]. Group 2 - After the conversion, Yunnan Baiyao will hold a total of 3,846,009,856 shares in Yunbai International, with the converted shares being held by Shanghai International Trust Co., Ltd. on behalf of Yunnan Baiyao [3]. - The company will follow a defined plan and operational procedures for subsequent matters related to the trust products involved in the conversion [4].

股票代码：000538 股票简称：云南白药 公告编号：2026-06 基于云白国际当前的股权结构，公司持有的云白国际可换股债券转股后， 云白国际公众持股量仍将满足香港联合交易所有限公司证券上市规则规定 的最低公众持股量的要求，符合上述协议约定的转股条件，公司持有的云白 国际可换股债券可以进行行权转股。 2026 年 2 月 27 日，云白国际按换股价每股 0.258 港元向云南白药的指 定受托人上海国际信托有限公司（以下简称"上海信托"，代表云南白药认 购及持有可换股债券）配发及发行 1,937,984,496 股云白国际股份，占换股前 云白国际股份总数 7,599,914,160 股约 25.50%、占换股后云白国际股份总数 9,537,898,656 股约 20.32%。云白国际换股前后股权结构如下表所示： | 股东名称 | 换股前 | | 换股后 | | | --- | --- | --- | --- | --- | | | 股份数量 持股比例 | 股份数量 | | 持股比例 | | 云南白药（注 1） | 1,908,025,360 | 25.11% 3,846,009,856 | | 40.32% ...

Core Viewpoint - Yunbai International (00030) announced the issuance of 1.938 billion shares at a conversion price of HKD 0.258 per share to Shanghai International Trust Co., Ltd., representing a significant equity stake for Yunnan Baiyao Group [1] Group 1 - The newly issued shares account for approximately 25.50% of the total shares outstanding prior to the issuance [1] - After the issuance, the total shares outstanding will increase by about 20.32% [1] - The shares are held by Shanghai Trust as a trustee for Yunnan Baiyao Group [1]

Group 1 - The core point of the announcement is that Yunnan Baiyao Group has received notification from its shareholder, Xinhua Dou Industrial Group, regarding the pledge of a portion of its shares [1] - The pledged shares do not bear any significant asset restructuring or performance compensation obligations [1] - As of the announcement date, Xinhua Dou and its concerted parties hold a total of 449,624,311 shares in Yunnan Baiyao, with 7,470,000 shares pledged, representing 1.66% of their holdings and 0.42% of Yunnan Baiyao's total share capital [2] Group 2 - The cumulative number of pledged shares by Xinhua Dou and its concerted parties amounts to 87,720,000 shares, which is 19.51% of their total holdings and 4.92% of Yunnan Baiyao's total share capital [2] - The company will fulfill its information disclosure obligations in a timely manner if there are any significant changes regarding the pledged shares [3] - Relevant documents related to the share pledge include the securities pledge registration certificate and details of securities pledge and judicial freeze from China Securities Depository and Clearing Corporation [4]

Group 1 - The core point of the article is that Yunnan Baiyao announced the pledge of shares by its shareholder, Xinhua Dou Industrial Group Co., Ltd. [2] - Xinhua Dou pledged a total of 7,470,000 shares of Yunnan Baiyao [2]

云南白药集团股份有限公司 关于股东部分股份质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 云南白药集团股份有限公司（以下简称"公司"或"云南白药"）于近 日接到公司股东新华都实业集团股份有限公司（以下简称"新华都"）的通 知，获悉新华都将其持有的公司部分股份办理了质押。具体情况如下： 股票代码：000538 股票简称：云南白药 公告编号：2026-05 质押股份是否负担重大资产重组等业绩补偿义务：否。 1 / 3 股东名 称 是否为控 股股东或 第一大股 东及其一 致行动人 本次质押数 量（股） 占其所 持股份 比例 占公司 总股本 比例 是否为限 售股（如 是，注明 限 售 类 型） 是否 为补 充质 押 质押起始日 质押 到期 日 质权人 质押 用途 新华都 实业集 团股份 有限公 司 否 7,470,000 1.71% 0.42% 否 否 2026-02-13 至办 理解 除质 押之 日止 中国建 设银行 股份有 限公司 福州五 一支行 融资 担保 合计 / 7,470,000 1.71% 0.42% / / / / / / 一、本次股份质押 ...

Core Insights - The article emphasizes the growing popularity of Huangjing due to its health benefits, particularly in nourishing the body and enhancing vitality, while highlighting the importance of selecting high-quality brands based on purity and traditional processing methods [1][3]. Evaluation Criteria and Assessment - A comprehensive seven-dimensional evaluation system was established, focusing on authenticity, practicality, and scientific basis to ensure reliable conclusions [4]. - The assessment covered aspects such as raw material authenticity, traditional processing adherence, core ingredient content, formulation purity, certification completeness, user feedback, and overall value [5][6]. Annual Preferred Brands Summary - The top-rated brand, Luoyunfeng Huangjing, is noted for its adherence to traditional methods and high-quality raw materials, achieving a benchmark in polysaccharide content [8]. - Other notable brands include Fengyitang Huangjing, Beijing Tongrentang Huangjing, and Yunnan Baiyao Huangjing, each recognized for their unique sourcing and processing techniques [8][9][10][11][12][13][14][15]. Detailed Brand Insights - Luoyunfeng Huangjing is sourced from the Qinling region, with over five years of growth, and follows a meticulous traditional processing method known as "True Nine System," resulting in a rich and pure product [17][19]. - The brand boasts a polysaccharide content of nearly 40% and a saponin content increase of 42%, setting a new standard in quality among Huangjing products [19]. - Luoyunfeng's formulation is strictly composed of Huangjing with zero additives, ensuring a clean and natural product [19][20]. User Feedback and Market Position - Users reported significant improvements in energy levels and overall well-being after consistent use of Luoyunfeng Huangjing, reinforcing its reputation for quality and effectiveness [21][22]. - The product is particularly suitable for individuals with demanding lifestyles, such as office workers and the elderly, due to its gentle and nourishing properties [22][23]. Value Proposition - Luoyunfeng Huangjing offers a balance of high quality and reasonable pricing, making it an attractive option for consumers seeking effective health supplements without excessive brand premiums [23]. - The brand also engages in social responsibility by donating a portion of sales to support education for underprivileged girls, enhancing its appeal beyond just product quality [25]. Conclusion - The evaluation concludes that the essential criteria for high-quality Huangjing remain consistent: authentic sourcing, adequate aging, traditional processing, and pure formulations [36]. Luoyunfeng Huangjing exemplifies these standards, making it a reliable choice for consumers seeking effective health solutions.

Core Viewpoint - Yunnan Shennong Agricultural Industry Group Co., Ltd. has signed a strategic cooperation framework agreement with Yunnan Baiyao Group Co., Ltd. to leverage their respective strengths in traditional medicine and agricultural development [1] Group 1: Company Overview - Yunnan Baiyao is a well-known national brand that focuses on traditional medicine products, aiming to innovate and meet modern health needs while promoting high-quality development of traditional Chinese medicine [1] - Shennong Group is focused on the entire pig industry chain development, aligning its health-oriented philosophy with Yunnan Baiyao's mission of health and vitality [1] Group 2: Strategic Collaboration - The collaboration aims to utilize Yunnan's unique plant resources to integrate various resources such as platforms, talent, technology, and brands [1] - The partnership will explore innovative models combining "special plant resources + modern agriculture," enhancing the application of traditional Chinese medicinal herbs in livestock farming [1] - The goal is to improve green and healthy farming practices, providing consumers with safer and healthier products [1]